$166.94
-2.0%Novanta Inc., together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. The company's Photonics segment offers photonics-based solutions, including laser scanning and beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products serving photonics-based applications for industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures. It's Vision segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; wireless technologies, video recorders, and video integration technologies for operating room integrations; optical data collection and machine vision technologies; radio frequency identification technologies; thermal chart recorders; spectrometry technologies; and embedded touch screen solutions. In addition, its Precision Motion segment offers optical and inductive encoders, precision motors, servo drives and motion control solutions, integrated stepper motors, intelligent robotic end-of-arm technology solutions, air bearings, and air bearing spindles. The company sells its products through its direct sales force, resellers, distributors, and system integrators under the Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, NDSsi, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, Celera Motion, MicroE, Zettlex, Applimotion, Ingenia, and Westwind brands. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was founded in 1968 and is headquartered in Bedford, Massachusetts.
Chief Accounting Officer & Corporate Controller
Chief Executive Officer & Chairman of the Board
Compensation
$1,486,834
Chief Financial Officer
Compensation
$820,530
Chief Human Resources Officer
Chief Information Officer & Chief Information Security Officer
Co-Chief Operating Officer of Automation Enabling Technologies
Co-Chief Operating Officer of Medical Solutions
Corporate Finance Leader & IR
General Counsel & Corporate Secretary
Compensation
$524,124
Group President of Medical Solutions
Senior Vice President of Corporate Development
Senior Vice President of Leadership Development and Diversity, Equity & Inclusion
During the last 12 months, insiders have sold $6.53M worth of NOVT shares, with no buying activity reported.
0
0.00
19.1K
2.54M
-2.5M
-$2.54M
0
0.00
29.1K
3.99M
-4.0M
-$3.99M
0
0.00
0
0.00
+0
+$0
0
0.00
0
0.00
+0
+$0
No buying activity
Glastra Matthijs
Director, Officer: Chief Executive Officer
$5.64M
Buckley Robert
Officer: Chief Financial Officer
$711K
Secor Thomas N
Director
$179K
Strong bearish signal with $6.53M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
3 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.
Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.
NOVT - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 24, 2026 | May 28, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 25, 2025 | May 29, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 03, 2024 | May 08, 2024 | 2024 | |
DEF 14A DEF 14A N/A | April 07, 2023 | April 07, 2023 | ||
DEF 14A DEF 14A 2022 N/A | April 08, 2022 | May 12, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | April 06, 2021 | May 13, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | April 20, 2020 | May 26, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | April 05, 2019 | May 09, 2019 | 2019 | |
DEF 14A DEF 14A 2018 N/A | April 06, 2018 | May 10, 2018 | 2018 | |
DEF 14A DEF 14A 2017 N/A | April 10, 2017 | May 10, 2017 | 2017 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.